株式会社メディファスト
US ˙ NYSE ˙ US58470H1014

SecurityMED / Medifast, Inc.
InsiderScott Schlackman
This page shows the track record and history of SCHLACKMAN SCOTT insider trades in Medifast, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Scott Schlackman in MED / Medifast, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
2026-05-11 2,500 12.5300 2,500 12.5300 31,325 17 13.1500 1,550 4.95
2026-05-08 2,500 12.6500 2,500 12.6500 31,625
2023-11-07 53 68.8900 53 68.8900 3,627
2023-08-08 40 89.4200 40 89.4200 3,561
2023-05-09 13 87.5000 13 87.5000 1,150
2023-02-07 10 114.9700 10 114.9700 1,127
2022-11-08 10 106.9300 10 106.9300 1,110

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MED / Medifast, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Scott Schlackman in MED / Medifast, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2024-03-08 1,300 39.4100 1,300 39.4100 51,233 363 13.7500 -33,358 -65.11
2024-03-08 2,753 39.4600 2,753 39.4600 108,633
2023-03-10 2,200 108.6800 2,200 108.6800 239,096
2021-05-19 904 310.0900 904 310.0900 280,321
2021-05-19 96 311.5700 96 311.5700 29,911
2020-06-04 1,619 107.3500 1,619 107.3500 173,800
2020-06-04 1,500 107.7700 1,500 107.7700 161,655
2019-03-08 1,010 130.6400 1,010 130.6400 131,946
2019-03-08 990 131.2100 990 131.2100 129,898
2019-03-05 2,500 129.8000 2,500 129.8000 324,500

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

MED / Medifast, Inc. Insider Trades
Insider Transaction History
File
Date		 Trade
Date		 Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price		 Unit
Price		 Units
Changed		 Value
Changed (1K)		 Remaining
Options		 Remaining
Shares
2026-05-28 2026-05-26 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 11,680 42,229
2026-05-12 2026-05-11 4 SCHLACKMAN SCOTT MED Common Stock P - Purchase D 12.5300 2,500 31 30,549
2026-05-12 2026-05-08 4 SCHLACKMAN SCOTT MED Common Stock P - Purchase D 12.6500 2,500 32 28,049
2025-06-26 2025-06-25 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 11,168 25,549
2024-06-24 2024-06-20 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 6,596 14,381
2024-03-12 2024-03-08 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 39.4600 -2,753 -109 7,785
2024-03-12 2024-03-08 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 39.4100 -1,300 -51 10,538
2024-03-12 2024-03-08 4 SCHLACKMAN SCOTT MED Common Stock M - Exercise D 27.6800 1,300 36 11,838
2023-11-09 2023-11-07 4 SCHLACKMAN SCOTT MED Common Stock P - Purchase D 68.8900 53 4 10,538
2023-08-10 2023-08-08 4 SCHLACKMAN SCOTT MED Common Stock P - Purchase D 89.4200 40 4 10,485
2023-06-20 2023-06-15 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 3,152 10,445
2023-05-11 2023-05-09 4 SCHLACKMAN SCOTT MED Common Stock P - Purchase D 87.5000 13 1 7,293
2023-03-14 2023-03-10 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 108.6800 -2,200 -239 7,280
2023-03-14 2023-03-10 4 SCHLACKMAN SCOTT MED Common Stock M - Exercise D 27.6800 2,200 61 9,480
2023-02-09 2023-02-07 4 SCHLACKMAN SCOTT MED Common Stock P - Purchase D 114.9700 10 1 7,280
2022-11-10 2022-11-08 4 SCHLACKMAN SCOTT MED Common Stock P - Purchase D 106.9300 10 1 7,270
2022-08-10 2022-08-08 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 138.7800 8 1 7,260
2022-06-21 2022-06-16 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 1,448 7,252
2021-06-30 2021-06-03 4/A SCHLACKMAN SCOTT MED Common Stock A - Award D 669 5,804
2021-06-07 2021-06-03 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 669 5,900
2021-05-21 2021-05-19 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 311.5700 -96 -30 5,135
2021-05-21 2021-05-19 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 310.0900 -904 -280 5,231
2020-06-18 2020-06-16 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 1,699 6,135
2020-06-08 2020-06-04 4 SCHLACKMAN SCOTT MED Stock Option (Right to Buy) M - Exercise D 27.68 -1,500 3,500
2020-06-08 2020-06-04 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 107.7700 -1,500 -162 4,436
2020-06-08 2020-06-04 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 107.3500 -1,619 -174 5,936
2020-06-08 2020-06-04 4 SCHLACKMAN SCOTT MED Common Stock M - Exercise D 27.6800 1,500 42 7,555
2019-03-12 2019-03-08 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 131.2100 -990 -130 6,055
2019-03-12 2019-03-08 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 130.6400 -1,010 -132 7,045
2019-03-07 2019-03-05 4 SCHLACKMAN SCOTT MED Stock Options M - Exercise D 28.59 -2,500 0
2019-03-07 2019-03-05 4 SCHLACKMAN SCOTT MED Common Stock S - Sale D 129.8000 -2,500 -324 8,055
2019-03-07 2019-03-05 4 SCHLACKMAN SCOTT MED Common Stock M - Exercise D 28.5900 2,500 71 10,555
2019-02-26 2019-02-22 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 1,054 8,055
2018-02-09 2018-02-07 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 1,619 7,001
2017-02-21 2017-02-16 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 2,639 5,382
2016-02-08 2016-02-04 4 SCHLACKMAN SCOTT MED Stock Option A - Award D 27.68 5,000 7,500
2016-02-08 2016-02-04 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 2,118 2,743
2015-09-17 2015-09-15 4 SCHLACKMAN SCOTT MED Stock Option A - Award D 28.59 2,500 2,500
2015-09-17 2015-09-15 4 SCHLACKMAN SCOTT MED Common Stock A - Award D 625 625
P
非デリバティブまたはデリバティブ証券の公開市場または非公開購入
S
非デリバティブ証券またはデリバティブ証券の公開市場または非公開売却
A
会社からの有価証券の交付、授与その他の取得 (オプション等)
C
デリバティブの転換
D
有価証券の会社への売却または譲渡
F
会社から受領した有価証券の一部を使用した、行使価格または納税義務のお支払い
G
内部者によるまたは内部者に対する有価証券の贈与
K
株式スワップと類似のヘッジ取引
M
会社から受け取ったデリバティブ証券 (オプションなど) の行使または転換
V
フォーム4により任意に報告した取引
J
その他 (取引を説明する脚注を含む)